| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.5 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |